Marginal Zone Lymphoma

general

A usually indolent mature B-cell lymphoma, arising from the marginal zone of lymphoid tissues. It is characterized by the presence of small to medium sized atypical lymphocytes. It comprises three entities, according to the anatomic sites involved: extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue, which affects extranodal sites (most often stomach, lung, skin, and ocular adnexa); nodal marginal zone B-cell lymphoma, which affects lymph nodes without evidence of ext

74

Centers

150

Active Trials

$1.9B

Cancer Funding

Specific Cancer Types(6)

Top Centers for Marginal Zone Lymphoma(74)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
89.3
2
NCI Comprehensive
High-Volume Research Center
78.0
3
NCI Comprehensive
High-Volume Research Center
71.1
4
NCI Comprehensive
High-Volume Research Center
70.1
5
NCI Comprehensive
Active Research Program
69.1
6
Active Research Program
69.1
7
NCI Comprehensive
Active Research Program
68.9
8
NCI Comprehensive
Active Research Program
67.1
9
Active Research Program
67.1
10
Active Research Program
67.1
11
BC CancerVancouver, BC
Active Research Program
67.1
12
NCI Comprehensive
Active Research Program
61.3
13
NCI Comprehensive
Active Research Program
61.3
14
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
61.3
15
NCI Comprehensive
Active Research Program
61.3
16
NCI Clinical
Active Research Program
61.3
17
NCI Comprehensive
Active Research Program
61.3
18
Active Research Program
61.3
19
NCI Comprehensive
Active Research Program
61.3
20
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
61.3
21
NCI Comprehensive
Active Research Program
61.3
22
Active Research Program
61.3
23
Active Research Program
61.3
24
Active Research Program
61.3
2554.9
26
NCI Comprehensive
Active Research Program
53.4
27
NCI Comprehensive
Active Research Program
52.4
28
NCI Comprehensive
Active Research Program
51.2
29
NCI Comprehensive
Active Research Program
51.2
30
NCI Comprehensive
Active Research Program
51.2
31
NCI Comprehensive
Active Research Program
51.2
32
NCI Clinical
Active Research Program
51.2
33
Active Research Program
51.2
34
NCI Clinical
Active Research Program
51.2
35
NCI Clinical
Active Research Program
51.2
36
Active Research Program
51.2
37
Active Research Program
51.2
38
Active Research Program
51.2
39
Active Research Program
51.2
40
Active Research Program
51.2
4151.2
42
Active Research Program
51.2
43
Active Research Program
51.2
4436.2
45
NCI Comprehensive
36.2
4636.2
47
NCI Comprehensive
36.2
48
NCI Comprehensive
36.2
49
NCI Comprehensive
36.2
5036.2
5136.2
5236.2
5336.2
5436.2
55
NCI Comprehensive
36.2
56
NCI Comprehensive
36.2
57
NCI Comprehensive
36.2
58
NCI Comprehensive
36.2
59
NCI Comprehensive
36.2
6036.2
6136.2
62
NCI Comprehensive
36.2
6336.2
64
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
36.2
6536.2
6636.2
6736.2
6836.2
6936.2
70
NCI Comprehensive
71
72
73
NCI Clinical
74

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →